1 Min Read
July 12 (Reuters) - Eli Lilly And Co
* UK Supreme Court confirms that products by Actavis would infringe Lilly's patent, dismisses Actavis' cross-appeal Source text: here Further company coverage: (London newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.